NCT06480279

Brief Summary

The elderly are at high risk of falls due to neurophysiological changes, such as motor and sensory impairment, that occur with aging. The incidence of falls in older adults is high, with approximately 30% of adults over the age of 65 falling at least once per year. Falls can lead to serious consequences such as fractures, hospitalization, and loss of independence. The changes in neurophysiology have also been found to decrease balance control in aging people, leading to postural instability. It is well-known that postural balance is influenced by sensory inputs, including touch, proprioception, vision, and vestibular, as well as motor output such as motor controls. Impairments in these systems contribute to postural instability and an increased risk of falling in the elderly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2024

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 28, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2025

Completed
Last Updated

September 25, 2025

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

June 13, 2024

Last Update Submit

September 21, 2025

Conditions

Keywords

Transcranial Magnetic StimulationQuantitative Sensory TestingFallsElderly

Outcome Measures

Primary Outcomes (11)

  • Montreal Cognitive Assessment (MoCA)

    MoCa is a screening test used to detect mild cognitive decline and early signs of dementia. The total score of the test is 30 points. The MoCA will be recored in scores.

    MoCA will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Body weight

    We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. The body weight will be recored in kilograms.

    Body weight will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Muscle mass

    We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. The muscle mass will be recored in kilograms.

    Muscle mass will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Body mass index (BMI)

    We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. The BMI will be recored in kg/m\^2.

    BMI will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Percent body fat

    We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. Percent body fat will be recored in percentage.

    Percent body fat will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • The duration during Timed Up and Go Test

    The Timed Up and Go Test (TUG) is a test for assessing fall risk. Participants will begin by sitting on a chair. They will be asked to stand up, walk 3 meters away at a comfortable speed, turn around a traffic cone, walk back, and sit down. TUG will be recored in second.

    TUG will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • The repetition of Chair Stand Test

    Chair Stand Test is used to test leg strength and endurance. Participants will begin by sitting on a chair. Participants will be instructed to stand up with full leg extension as quickly as possible, sit back down as quickly as possible, andrepeat this process for 30 seconds. Chair Stand Test will be recorded in repetition.

    Chair Stand Test will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Muscle evoke potential (MEP)

    Participants will be stimulated at the primary motor cortex by transcranial magnetic stimulation to measure cortical excitability, which sends the motor outputs to Tibialis Anterior (TA) and Abductor Pollicis Brevis (APB) muscles. The MEP will be used to assess muscle activity in these muscles during the stimulation. The MEP will be measured in mV.

    Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Cortical silent period (CSP)

    Participants will be stimulated at the primary motor cortex by transcranial magnetic stimulation to measure cortical excitability, which sends the motor outputs to Tibialis Anterior (TA) and Abductor Pollicis Brevis (APB) muscles. The CSP will be used to assess muscle activity in these muscles during the stimulation. The CSP will be measured in ms.

    Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Cold temperature threshold

    Participants will be stimulated by Quantitative Sensory Testing (QST) with cold temperature on their legs. QST is the standard device validated by the manufacturer and approved for use in research assessments, as demonstrated in the supplementary files. Cold temperature threshold will be measure in degree Celsius.

    Cold temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

  • Vibration threshold

    Participants will be stimulated by Quantitative Sensory Testing (QST) with vibration threshold on their legs. QST is the standard device validated by the manufacturer and approved for use in research assessments, as demonstrated in the supplementary files. Vibration threshold will be measure in μm.

    Vibration temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Study Arms (4)

Non-fallers

Elderly without history of fall

Fallers-low risk

Elderly with a history of falling 1 time within the last year.

Fallers-moderate risk

Elderly with a history of falling twice within the last year.

Fallers-high risk

Elderly with a history of falling \>2 times within the last year.

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Thai elderly who have received check-ups or treatment at King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

You may qualify if:

  • \) Male and female individuals aged 65-80 years.

You may not qualify if:

  • History of previous lower limb surgery, such as total knee replacement or ankle surgery.
  • History of a neurological disorder, such as stroke or Parkinson's disease.
  • History of vestibular disease, such as Meniere's disease.
  • History of seizures or epilepsy.
  • The presence of metal implanted devices in or around the head area
  • MoCA score \< 26

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medicine, Faculty of Medicine, Chulalongkorn University.

Bangkok, 10330, Thailand

Location

Study Officials

  • Jakkrit Amornvit, MD

    Chulalongkorn University

    PRINCIPAL INVESTIGATOR
  • Phunsuk Kantha, PT.,PhD

    Mahidol University

    PRINCIPAL INVESTIGATOR
  • Kulvara Lapanan, PT

    Chulalongkorn University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2024

First Posted

June 28, 2024

Study Start

May 16, 2024

Primary Completion

May 16, 2025

Study Completion

August 16, 2025

Last Updated

September 25, 2025

Record last verified: 2024-06

Locations